Supplementary Table 3.
Outcomes of intracytoplasmic sperm injection treatments
| Cycles | Protocol | Initiation | Number of oocytes | Insemination method | Number of MII oocytes | Number of fertilized oocytes | Number of 2PN oocytes | Number of cleaved embryos | Number of embryos on day3 | Classification of cleaved embryos |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GnRH protocol | Gonal-F 75 IU + HMG 75 IU | 12 | TESA-ICSI | 7 | 6 | 6 | 6 | 6 | 6C4*4, 5C4, and 3C4 |
| 2 | GnRH protocol | Puregon 75 IU + HMG 75 IU | 14 | TESA-ICSI | 11 | 8 | 8 | 6 | 6 | 6C3*2, 4C3*2, and 5C3*2 |
| 3 | Long-acting GnRH protocol | Puregon 100 IU + HMG 75 IU | 7 | TESA-ICSI | 4 | 4 | 4 | 4 | 4 | 4C4*3 and 3C4 |
| 4 | PPOS protocol | Puregon 100 IU + HMG 75 IU | 10 | TESA-ICSI | 7 | 7 | 6 | 6 | 6 | 5C3*3, 2C4, sand 3C4*2 |
HMG: human menopausal gonadotropin; TESA: testicular sperm aspiration; ICSI: intracytoplasmic sperm injection; PPOS: progestin-primed ovarian stimulation